Neuroscience
Parkinson's Disease
100%
positron emission tomographic scan
65%
Phosphodiesterase
44%
Molecular Imaging
37%
Huntington's Disease
35%
In Vivo
25%
Single-Photon Emission Computed Tomography
19%
Dopaminergic
18%
Meta-Analysis
17%
Magnetic Resonance Imaging
14%
Progressive Supranuclear Palsy
14%
Metabolic Pathway
13%
Dyskinesia
12%
Cholinergic
12%
Non-Motor Symptoms
12%
Cognitive Disorders
11%
Striatum
11%
L-DOPA
11%
Basal Ganglia
11%
Diabetes Mellitus
11%
Putamen
10%
Multiple System Atrophy
10%
Atypical Parkinsonism
10%
Fluorine-18
10%
Gray Matter
10%
Neurodegenerative Disorder
9%
Positron Emission Tomography
9%
Adenylyl Cyclase
8%
Sleep Disorder
8%
Spectrum Disorder
8%
Denervation
8%
Serotonin Transporter
8%
Nervous System Disorder
8%
Daytime Somnolence
8%
Iodine-123
8%
Neurodegeneration
7%
Thalamus
6%
Differential Diagnosis
5%
Dopamine Receptor
5%
Acetylcholinesterase
5%
Alzheimer's Disease
5%
Globus pallidus
5%
Mild Cognitive Impairment
5%
Medicine and Dentistry
Positron Emission Tomography
38%
Parkinson's Disease
27%
Molecular Imaging
20%
Progressive Supranuclear Palsy
11%
Disease Exacerbation
10%
Dopaminergic System
10%
Atypical Parkinsonism
10%
Systematic Review
9%
Meta-Analysis
8%
Shy-Drager Syndrome
8%
Serotonin Transporter
8%
Huntington's Disease
8%
Single-Photon Emission Computed Tomography
7%
Carbon 11
6%
Differential Diagnosis
5%
Dopamine Receptor
5%
Polyethylene Terephthalate
5%
Pharmacology, Toxicology and Pharmaceutical Science
Parkinson's Disease
31%
Huntington Chorea
17%
Dopamine Receptor Stimulating Agent
15%
Polyethylene Terephthalate
13%
Cholinergic Receptor Stimulating Agent
13%
Progressive Supranuclear Palsy
11%
Pathophysiology
10%
Phosphodiesterase
10%
Cognitive Defect
10%
Disease Exacerbation
9%
Carbon 11
9%
Levodopa-Induced Dyskinesia
8%
Parkinsonism
8%
Diseases
8%
Shy Drager Syndrome
7%
Dopamine Receptor
5%
Acetylcholinesterase
5%
Biological Marker
5%
